Nanion today announces the opening of Nanion Technologies Inc. with headquarters in North Brunswick, NJ, USA. To support the increasing demand of Nanion’s products, and to continue giving premium customer service, Nanion now expands its presence in the American market.
Nanion opens the doors to the US-office in the “Heart of Pharma”, North Brunswick, NJ. Nanion Technologies Inc. has a fully equipped demonstration and service center for North America, supporting the Port-a-Patch and the Patchliner, and from the end of the year, the SyncroPatch 96. Nanion’s demonstration site is located in Chromocell’s newly built laboratory space. Nanion and Chromocell, a leader in the creation of previously inaccessible drug targets, are engaged in a research partnership.
“With the rapidly growing number of American customers, we need to increase our efforts in the North American market which will strengthen our position as a leading provider of sophisticated and high quality ion channel screening devices. Additionally, swift and competent technical support is very important to us and has always been our trademark. To expand and support the sales in the US, our US-office will make it easier for people to visit us and see our platforms in action.” says Dr. Niels Fertig, CEO of Nanion Technologies.
Rodolfo Haedo, General Manager and Chief Application Scientist, recently joined the Nanion team to support the US customers from the headquarters in North Brunswick. Mr. Haedo has extensive electrophysiology background and valuable experience of various automated patch clamp platforms. Rodolfo Haedo was previously employed at Merck, Rahway, NJ where he was member of Merck’s well renowned ion channel group.
“Rodolfo Haedo’s background in automated electrophysiology is impressive and he is a very good fit for Nanion, especially since we now are in the phase of introducing the SyncroPatch 96, our HTS patch clamp platform. We are very happy to welcome him on board and look forward to a very exciting year!” continues Dr. Fertig.
“I am thrilled to join the Nanion team and to support and promote Nanion’s impressive platforms in the American market. The SyncroPatch 96 is a unique platform considering data quality, throughput, cost efficiency and performance. The platform has the highest throughput on the market, given the data quality, and I am convinced it will be a success because of its enabling screening features.” says Rodolfo Haedo.
With the opening of the US-office, Nanion Technologies Inc. will offer its products in US-dollars for the North American customers.
Nanion opens the doors to the US-office in the “Heart of Pharma”, North Brunswick, NJ. Nanion Technologies Inc. has a fully equipped demonstration and service center for North America, supporting the Port-a-Patch and the Patchliner, and from the end of the year, the SyncroPatch 96. Nanion’s demonstration site is located in Chromocell’s newly built laboratory space. Nanion and Chromocell, a leader in the creation of previously inaccessible drug targets, are engaged in a research partnership.
“With the rapidly growing number of American customers, we need to increase our efforts in the North American market which will strengthen our position as a leading provider of sophisticated and high quality ion channel screening devices. Additionally, swift and competent technical support is very important to us and has always been our trademark. To expand and support the sales in the US, our US-office will make it easier for people to visit us and see our platforms in action.” says Dr. Niels Fertig, CEO of Nanion Technologies.
Rodolfo Haedo, General Manager and Chief Application Scientist, recently joined the Nanion team to support the US customers from the headquarters in North Brunswick. Mr. Haedo has extensive electrophysiology background and valuable experience of various automated patch clamp platforms. Rodolfo Haedo was previously employed at Merck, Rahway, NJ where he was member of Merck’s well renowned ion channel group.
“Rodolfo Haedo’s background in automated electrophysiology is impressive and he is a very good fit for Nanion, especially since we now are in the phase of introducing the SyncroPatch 96, our HTS patch clamp platform. We are very happy to welcome him on board and look forward to a very exciting year!” continues Dr. Fertig.
“I am thrilled to join the Nanion team and to support and promote Nanion’s impressive platforms in the American market. The SyncroPatch 96 is a unique platform considering data quality, throughput, cost efficiency and performance. The platform has the highest throughput on the market, given the data quality, and I am convinced it will be a success because of its enabling screening features.” says Rodolfo Haedo.
With the opening of the US-office, Nanion Technologies Inc. will offer its products in US-dollars for the North American customers.
